Stephen Jurvetson Overview
- Investor Type
-
Angel
- Investments
-
7
- Portfolio
-
2
- Exits
-
4

Stephen Jurvetson General Information
Description
Mr. Stephen Jurvetson is a Co-Founder of Future Ventures (San Francisco). Mr. Jurvetson served as an Advisor at Cleartrace and Deep Genomics. He is an Investor of Upside Foods. He serves as a Board Member at SpaceX & ZaiNar. He also serves as a Board Observer at Zyphra. He served as a Board Member & Member of Audit Committee & Disclosure Control Committee at Tesla. He serves as a Board Observer at Cambrian. He served as a Board Member at Planet, Flux, and Synthetic Genomics. He is an Angel Investor. He also co-founded and served as its Partner, Venture Team at Draper Fisher Jurvetson. He was the founding VC investor in Hotmail, Interwoven (IWOV), Kana (KANA), and NeoPhotonics (NPTN). He also led DFJ's investments in other companies that were acquired for $12 billion in aggregate. Previously, he was an R&D Engineer at Hewlett-Packard, where seven of his communications chip designs were fabricated. His prior technical experience also includes programming, materials science research, and computer design at HP's PC Division, the Center for Materials Research, and Mostek. He has also worked in product marketing at Apple and NeXT Software. He served as a Board Member at eSionic. As a consultant with Bain & Company, he developed executive marketing, sales, engineering, and business strategies for a wide range of companies in the software, networking, and semiconductor industries, He served as Board Observer at Genomatica.
Business Details
Primary Investor Type
Corporate Office
- 465 1st Street
- Los Altos, CA 94022
- United States
Stephen Jurvetson Investments (7)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Superplum | 21-May-2021 | Seed Round | Logistics | Generating Revenue | ||
Sensei Biotherapeutics | 11-Jan-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
ATAI Life Sciences | 23-Nov-2020 | Drug Discovery | Generating Revenue/Not Profitable | |||
nCent | 01-Jul-2018 | Financial Software | Generating Revenue | |||
PurePlay | 03-Jan-2007 | Casinos and Gaming | Out of Business | |||
Longitude Systems | 13-Nov-2001 | Early Stage VC | Communication Software | Generating Revenue | ||
Superplum | Angel (individual) | Logistics | Generating Revenue |
Stephen Jurvetson Exits (4)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
ATAI Life Sciences | 18-Jun-2021 | IPO | |
Sensei Biotherapeutics | 04-Feb-2021 | ||
PurePlay | 01-Oct-2018 | Out of Business | |
Longitude Systems | 27-Nov-2001 | Merger/Acquisition |
Stephen Jurvetson Investments by Industry, Year, and Region
Stephen Jurvetson Co-Investors (16)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Apeiron Investment Group | 1 |
![]() |
![]() |
||
Binny Bansal |
![]() |
![]() |
|||
Daniel Rose |
![]() |
![]() |
|||
Mark Siegel |
![]() |
![]() |
|||
Pura Vida Investments |
![]() |
![]() |
Stephen Jurvetson FAQs
-
Who is Stephen Jurvetson?
Stephen Jurvetson is an angel Investor who has made 7 investments.
-
What kind of investor is Stephen Jurvetson?
Stephen Jurvetson is an angel investor.
-
What does Stephen Jurvetson do?
As an angel investor, Stephen Jurvetson invests personal money into promising companies, typically in exchange for equity.
-
How many board seats does Stephen Jurvetson hold?
Stephen Jurvetson holds a board seat in TMC The Metals Company.
-
What has Stephen Jurvetson invested in?
Stephen Jurvetson has made numerous investments in companies like Superplum, Sensei Biotherapeutics, and ATAI Life Sciences within the Logistics and Drug Discovery industries.
-
What has Stephen Jurvetson invested in recently?
Stephen Jurvetson's latest investment was on 21-May-2021 in Superplum, a company within the Logistics industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »